Predictions
Interpace Biosciences Inc.
Start price
Target price
Perf. (%)
€3.62
14.10.20
14.10.20
€2.00
17.10.20
17.10.20
-9.39%
17.10.20
17.10.20
Risky Investment
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.20
14.10.20
14.10.20
€8.00
04.11.21
04.11.21
181.22%
05.11.21
05.11.21
Diageo plc
Start price
Target price
Perf. (%)
€29.99
14.10.20
14.10.20
€38.00
04.11.21
04.11.21
4.24%
10.11.20
10.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€126.00
14.10.20
14.10.20
€120.00
16.10.20
16.10.20
-0.76%
16.10.20
16.10.20
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Sierra Wireless Inc.
Start price
Target price
Perf. (%)
€10.04
14.10.20
14.10.20
€15.00
04.11.21
04.11.21
38.71%
05.11.21
05.11.21
Coeur Mining Inc.
Start price
Target price
Perf. (%)
€6.88
14.10.20
14.10.20
-
04.11.21
04.11.21
-14.25%
30.11.20
30.11.20
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Very small cyclical dependencies
Eldorado Gold Corp.
Start price
Target price
Perf. (%)
€11.20
14.10.20
14.10.20
-
29.10.20
29.10.20
-5.31%
29.10.20
29.10.20
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Automatic Data Processing Inc
Start price
Target price
Perf. (%)
€127.42
13.10.20
13.10.20
€170.00
04.11.21
04.11.21
54.07%
05.11.21
05.11.21
Editas Medicine Inc
Start price
Target price
Perf. (%)
€27.82
13.10.20
13.10.20
€24.30
04.11.21
04.11.21
-6.72%
04.11.20
04.11.20
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€23.20
13.10.20
13.10.20
€19.20
04.11.21
04.11.21
-28.28%
22.12.20
22.12.20
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.76
13.10.20
13.10.20
€2.90
28.10.20
28.10.20
-8.43%
28.10.20
28.10.20
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
NIO Inc. ADR
Start price
Target price
Perf. (%)
€18.25
13.10.20
13.10.20
€34.00
04.11.21
04.11.21
105.59%
05.11.21
05.11.21
Probably not worthwhile Investment
Visteon Corporation
Start price
Target price
Perf. (%)
€69.00
13.10.20
13.10.20
€107.00
04.11.21
04.11.21
55.07%
05.11.21
05.11.21
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€236.45
13.10.20
13.10.20
€250.00
04.11.21
04.11.21
4.67%
05.11.20
05.11.20
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth >5% per year expected